ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii

被引:51
作者
Arend, SM
de Haas, P
Leyten, E
Rosenkrands, I
Rigouts, L
Andersen, P
Mijs, W
van Dissel, JT
van Soolingen, D
机构
[1] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2300 RC Leiden, Netherlands
[2] Natl Inst Publ Hlth & Environm, Dept Mycobacteria, NL-3720 BA Bilthoven, Netherlands
[3] State Serum Inst, Dept Infect Dis Immunol, Copenhagen, Denmark
[4] Innogenet NV, Ghent, Belgium
[5] Inst Trop Med, Mycobacteriol Unit, B-2000 Antwerp, Belgium
关键词
D O I
10.1086/428950
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mycobacterium kansasii consists of 5 genetically distinct groups, of which 2 are associated with human disease. Determinants of the differences in virulence are unknown. Potential genes of interest are esat-6 and cfp-10, which are associated with virulence of Mycobacterium tuberculosis and Mycobacterium bovis but are lacking in bacille Calmette-Guerin and in most environmental mycobacteria ( M. kansasii is an exception). We investigated esat-6 and cfp-10 genes in 22 clinical and 14 environmental isolates of M. kansasii. Both were present in all isolates; each genetic group had its own characteristic Southern-blot pattern corresponding to a highly conserved fingerprint pattern. Nucleotide sequences of the genes differed 12.6% and 10.1%, respectively, from the M. tuberculosis homologues, but the deduced amino acid sequences were <5% different. In vitro, clinical and environmental genotypes of M. kansasii expressed CFP-10 and ESAT-6. Thus, virulence of M. kansasii is not directly related to esat-6 and cfp-10 genes or gene expression.
引用
收藏
页码:1301 / 1310
页数:10
相关论文
共 43 条
[11]   Pulmonary Mycobacterium kansasii infection: Comparison of radiological appearances with pulmonary tuberculosis [J].
Evans, AJ ;
Crisp, AJ ;
Hubbard, RB ;
Colville, A ;
Evans, SA ;
Johnston, IDA .
THORAX, 1996, 51 (12) :1243-1247
[12]   Pulmonary Mycobacterium kansasii infection: Comparison of the clinical features, treatment and outcome with pulmonary tuberculosis [J].
Evans, SA ;
Colville, A ;
Evans, AJ ;
Crisp, AJ ;
Johnston, IDA .
THORAX, 1996, 51 (12) :1248-1252
[13]   Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG [J].
Harboe, M ;
Oettinger, T ;
Wiker, HG ;
Rosenkrands, I ;
Andersen, P .
INFECTION AND IMMUNITY, 1996, 64 (01) :16-22
[14]   CHARACTERIZATION OF A MAJOR POLYMORPHIC TANDEM REPEAT IN MYCOBACTERIUM-TUBERCULOSIS AND ITS POTENTIAL USE IN THE EPIDEMIOLOGY OF MYCOBACTERIUM-KANSASII AND MYCOBACTERIUM-GORDONAE [J].
HERMANS, PWM ;
VANSOOLINGEN, D ;
VANEMBDEN, JDA .
JOURNAL OF BACTERIOLOGY, 1992, 174 (12) :4157-4165
[15]   The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue [J].
Hsu, T ;
Hingley-Wilson, SM ;
Chen, B ;
Chen, M ;
Dai, AZ ;
Morin, PM ;
Marks, CB ;
Padiyar, J ;
Goulding, C ;
Gingery, M ;
Eisenberg, D ;
Russell, RG ;
Derrick, SC ;
Collins, FM ;
Morris, SL ;
King, CH ;
Jacobs, WR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12420-12425
[16]   CHARACTERIZATION OF PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN BY USE OF MONOCLONAL-ANTIBODIES - ISOLATION OF A DELAYED-TYPE HYPERSENSITIVITY REACTIVE COMPONENT FROM MYCOBACTERIUM-TUBERCULOSIS CULTURE FILTRATE [J].
KLAUSEN, J ;
MAGNUSSON, M ;
ANDERSEN, AB ;
KOCH, C .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1994, 40 (03) :345-349
[17]   Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells [J].
Lalvani, A ;
Pathan, AA ;
Durkan, H ;
Wilkinson, KA ;
Whelan, A ;
Deeks, JJ ;
Reece, WHH ;
Latif, M ;
Pasvol, G ;
Hill, AVS .
LANCET, 2001, 357 (9273) :2017-2021
[18]  
LANGERMANS JAM, 2005, IN PRESS VACCINE
[19]   Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation [J].
Lewis, KN ;
Liao, RL ;
Guinn, KM ;
Hickey, MJ ;
Smith, S ;
Behr, MA ;
Sherman, DR .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (01) :117-123
[20]   Therapy of tuberculosis in mice by DNA vaccination [J].
Lowrie, DB ;
Tascon, RE ;
Bonato, VLD ;
Lima, VMF ;
Faccioli, LH ;
Stavropoulos, E ;
Colston, MJ ;
Hewinson, RG ;
Moelling, K ;
Silva, CL .
NATURE, 1999, 400 (6741) :269-271